Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / KZR - Kala PDUFA And Other News: The Good Bad And Ugly Of Biopharma

KZR - Kala PDUFA And Other News: The Good Bad And Ugly Of Biopharma

Kezar Life Sciences Inc.
  • Kala Pharmaceuticals on the go with upcoming PDUFA.
  • Kezar announces Phase 2 KZR-616 trial update for polymyositis and dermatomyositis.
  • Mirati Therapeutics announces positive clinical data for adagrasib.

For further details see:

Kala PDUFA, And Other News: The Good, Bad And Ugly Of Biopharma
Stock Information
Company Name: Kezar Life Sciences Inc.
Stock Symbol: KZR
Market: NASDAQ
Website: kezarlifesciences.com
Menu
KZR KZR Quote KZR Short KZR News KZR Articles KZR Message Board
Get KZR Alerts

News, Short Squeeze, Breakout and More Instantly...